US approves Pfizer's maternal RSV vaccine to protect infants

The approval allows the vaccine to be given to women 32 to 36 weeks into a pregnancy to prevent lower respiratory tract infection and...

Related Keywords

Kano , Nigeria , United States , American , Peter Marks , National Institutes Of Health , Centre For Biologics Evaluation , Drug Administration On Monday , Pfizer , American Food , Drug Administration , Respiratory Syncytial Virus , Biologics Evaluation , National Institutes , How Pfizer ,